Logo image of OCUL

OCULAR THERAPEUTIX INC (OCUL) Stock Earnings Estimates

USA - Nasdaq - NASDAQ:OCUL - US67576A1007 - Common Stock

10.27 USD
-0.85 (-7.64%)
Last: 1/23/2026, 8:26:37 PM
10.3699 USD
+0.1 (+0.97%)
After Hours: 1/23/2026, 8:26:37 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
OCUL revenue by date.OCUL revenue by date.
51.49M
18.31%
58.443M
13.50%
63.723M
9.03%
55.883M
-12.30%
62.565M
11.96%
112.5M
79.81%
225.44M
100.39%
597.47M
165.02%
897.79M
50.27%
1.248B
39.01%
1.633B
30.85%
2.001B
22.54%
EBITDA
YoY % growth
OCUL ebitda by date.OCUL ebitda by date.
-76.54M
-1.22%
-79.399M
-3.74%
-167.995M
-111.58%
-271.83M
-61.81%
1.616B
694.49%
-141.525M
-108.76%
-144.034M
-1.77%
72.614M
150.41%
183.92M
153.28%
277.78M
51.03%
352.63M
26.95%
434.66M
23.26%
EBIT
YoY % growth
OCUL ebit by date.OCUL ebit by date.
-78.65M
-0.78%
-82.382M
-4.75%
-171.781M
-108.52%
-276.453M
-60.93%
-314.015M
-13.59%
-253.197M
19.37%
-244.394M
3.48%
5.642M
102.31%
249.83M
4,328.04%
512.86M
105.28%
806.36M
57.23%
1.109B
37.53%
Operating Margin
OCUL operating margin by date.OCUL operating margin by date.
-152.75%-140.96%-269.57%-494.70%-501.90%-225.06%-108.41%0.94%27.83%41.09%49.38%55.42%
EPS
YoY % growth
OCUL eps by date.OCUL eps by date.
-0.96
-966.67%
-1.17
-21.87%
-1.47
-25.64%
-1.50
-1.87%
-1.46
2.49%
-1.13
22.72%
-0.63
43.95%
0.32
150.00%
0.79
148.39%
1.17
49.35%
1.48
26.09%
1.81
22.07%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.33
-14.58%
-0.36
6.51%
-0.37
5.96%
-0.38
-0.08%
-0.39
-16.43%
-0.29
19.61%
-0.21
41.60%
-0.09
75.86%
-0.04
89.45%
Revenue
Q2Q % growth
16.451M
-3.70%
14.34M
34.04%
15.227M
13.14%
15.568M
7.04%
16.642M
1.16%
21.191M
47.78%
33.017M
116.83%
54.096M
247.48%
67.565M
305.99%
EBITDA
Q2Q % growth
-73.797M
-57.72%
-72.359M
-14.97%
-73.766M
-12.39%
-75.205M
-14.60%
-76.663M
-3.88%
-63.791M
11.84%
-47.501M
35.61%
-22.022M
70.72%
-8.211M
89.29%
EBIT
Q2Q % growth
-72.437M
-43.22%
-76.485M
-19.66%
-80.305M
-18.72%
-83.112M
-20.98%
-86.307M
-19.15%
-63.791M
16.60%
-47.501M
40.85%
-22.022M
73.50%
-8.211M
90.49%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.38
-72.73%
-0.37-0.01-1.62%
Q2 2025
Q2Q % growth
-0.39
-50.00%
-0.36-0.03-7.83%
Q1 2025
Q2Q % growth
-0.38
45.71%
-0.30-0.08-26.63%
Q4 2024
Q2Q % growth
-0.29
17.14%
-0.26-0.03-12.97%
Q3 2024
Q2Q % growth
-0.22
-29.41%
-0.250.0310.95%
Q2 2024
Q2Q % growth
-0.26 -0.23-0.03-15.12%
Q1 2024
Q2Q % growth
-0.70
-79.49%
-0.20-0.50-258.50%
Q4 2023
Q2Q % growth
-0.35
-45.83%
-0.31-0.04-12.87%
Q3 2023
Q2Q % growth
-0.17
45.16%
-0.290.1241.99%
Q2 2023
Q2Q % growth
-0.26
-4.00%
-0.310.0515.60%
Q1 2023
Q2Q % growth
-0.39
-143.75%
-0.27-0.12-45.11%
Q4 2022
Q2Q % growth
-0.24
-380.00%
-0.260.027.12%
Q3 2022
Q2Q % growth
-0.31
-1,133.33%
-0.24-0.07-27.70%
Q2 2022
Q2Q % growth
-0.25
-127.27%
-0.23-0.02-6.56%
Q1 2022
Q2Q % growth
-0.16
-500.00%
-0.270.1139.67%
Q4 2021
Q2Q % growth
-0.05
95.87%
-0.240.1979.14%
Q3 2021
Q2Q % growth
0.03
114.29%
-0.270.30111.10%
Q2 2021
Q2Q % growth
-0.11
82.81%
-0.220.1149.84%
Q1 2021
Q2Q % growth
0.04
109.76%
-0.210.25118.98%
Q4 2020
Q2Q % growth
-1.21 -0.17-1.04-611.75%
Q3 2020
Q2Q % growth
-0.21 -0.250.0415.10%
Q2 2020
Q2Q % growth
-0.64 -0.32-0.32-102.40%
Q1 2020
Q2Q % growth
-0.41 -0.38-0.03-8.64%
OCUL Yearly EPS VS EstimatesOCUL Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 -1 -2
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
14.544M
-5.71%
14.919M-375K-2.51%
Q2 2025
Q2Q % growth
13.459M
-18.14%
13.518M-59K-0.44%
Q1 2025
Q2Q % growth
10.698M
-27.59%
17.169M-6.471M-37.69%
Q4 2024
Q2Q % growth
17.083M
15.41%
17.549M-466K-2.66%
Q3 2024
Q2Q % growth
15.425M
2.28%
17.484M-2.059M-11.78%
Q2 2024
Q2Q % growth
16.441M
8.26%
16.14M301K1.86%
Q1 2024
Q2Q % growth
14.774M
10.47%
15.722M-948K-6.03%
Q4 2023
Q2Q % growth
14.802M
5.13%
16.021M-1.219M-7.61%
Q3 2023
Q2Q % growth
15.081M
25.99%
15.558M-477K-3.07%
Q2 2023
Q2Q % growth
15.186M
23.77%
14.943M243K1.63%
Q1 2023
Q2Q % growth
13.374M
1.39%
14.378M-1.004M-6.98%
Q4 2022
Q2Q % growth
14.08M
14.38%
13.804M276K2.00%
Q3 2022
Q2Q % growth
11.97M
-1.48%
14.556M-2.586M-17.77%
Q2 2022
Q2Q % growth
12.27M
4.69%
14.532M-2.262M-15.57%
Q1 2022
Q2Q % growth
13.19M
79.70%
14.48M-1.29M-8.91%
Q4 2021
Q2Q % growth
12.31M
67.48%
14.727M-2.417M-16.41%
Q3 2021
Q2Q % growth
12.15M
106.63%
12.703M-553K-4.35%
Q2 2021
Q2Q % growth
11.72M
646.50%
11.042M678K6.14%
Q1 2021
Q2Q % growth
7.34M
181.23%
7.789M-449K-5.76%
Q4 2020
Q2Q % growth
7.35M 9.954M-2.604M-26.16%
Q3 2020
Q2Q % growth
5.88M 5.601M279K4.98%
Q2 2020
Q2Q % growth
1.57M 1.529M41K2.68%
Q1 2020
Q2Q % growth
2.61M 2.897M-287K-9.91%
OCUL Yearly Revenue VS EstimatesOCUL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B 1.5B 2B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 4.51% 0% -0.39%
Revenue0% -0.9% 0% -0.51%